Furthermore, understanding the complex role of the tumor microenvironment is vital in order to propose and develope new treatment approaches in these cancers; this is mainly because some tumor environment-secreted factors, such as VEGF and TGF-β, are important regulators of therapeutic antibody blocking efficiency at certain immune checkpoints [36]. This evidence concerns the gene TGFB1 and neoplasm.